eCite Digital Repository

Quality use of medicines in patients with chronic kidney disease


Castelino, RL and Saunder, T and Kitsos, A and Peterson, GM and Jose, M and Wimmer, B and Khanam, M and Bezabhe, W and Stankovich, J and Radford, J, Quality use of medicines in patients with chronic kidney disease, BMC Nephrology, 21 pp. 1-9. ISSN 1471-2369 (2020) [Refereed Article]


Copyright Statement

Copyright 2020 The Authors. Licensed under Creative Commons Attribution 4.0 International (CC BY 4.0)

DOI: doi:10.1186/s12882-020-01862-1


Background: Chronic kidney disease (CKD) affects drug elimination and patients with CKD require appropriate adjustment of renally cleared medications to ensure safe and effective pharmacotherapy. The main objective of this study was to determine the extent of potentially inappropriate prescribing (PIP; defined as the use of a contraindicated medication or inappropriately high dose according to the kidney function) of renally-cleared medications commonly prescribed in Australian primary care, based on two measures of kidney function. A secondary aim was to assess agreement between the two measures.

Methods: Retrospective analysis of routinely collected de-identified Australian general practice patient data (NPS MedicineWise MedicineInsight from January 1, 2013, to June 1, 2016; collected from 329 general practices). All adults (aged ≥18 years) with CKD presenting to general practices across Australia were included in the analysis. Patients were considered to have CKD if they had two or more estimated glomerular filtration rate (eGFR) recorded values < 60 mL/min/1.73m2 , and/or two urinary albumin/creatinine ratios ≥3.5 mg/mmol in females (≥2.5 mg/mmol in males) at least 90 days apart. PIP was assessed for 49 commonly prescribed medications using the CockcroftGault (CG) equation/eGFR as per the instructions in the Australian Medicines Handbook.

Results: A total of 48,731 patients met the Kidney Health Australia (KHA) definition for CKD and had prescriptions recorded within 90 days of measuring serum creatinine (SCr)/estimated glomerular filtration rate (eGFR). Overall, 28, 729 patients were prescribed one or more of the 49 medications of interest. Approximately 35% (n = 9926) of these patients had at least one PIP based on either the Cockcroft-Gault (CG) equation or eGFR (CKD-EPI; CKDEpidemiology Collaboration Equation). There was good agreement between CG and eGFR while determining the appropriateness of medications, with approximately 97% of the medications classified as appropriate by eGFR also being considered appropriate by the CG equation.

Conclusion: This study highlights that PIP commonly occurs in primary care patients with CKD and the need for further research to understand why and how this can be minimised. The findings also show that the eGFR provides clinicians a potential alternative to the CG formula when estimating kidney function to guide drug appropriateness and dosing.

Item Details

Item Type:Refereed Article
Keywords:chronic kidney disease, prescribing, general practice, e-health records
Research Division:Health Sciences
Research Group:Health services and systems
Research Field:Primary health care
Objective Division:Health
Objective Group:Clinical health
Objective Field:Clinical health not elsewhere classified
UTAS Author:Saunder, T (Mr Timothy Saunder)
UTAS Author:Kitsos, A (Mr Alex Kitsos)
UTAS Author:Peterson, GM (Professor Gregory Peterson)
UTAS Author:Jose, M (Professor Matthew Jose)
UTAS Author:Wimmer, B (Dr Barbara Wimmer)
UTAS Author:Khanam, M (Dr Masuma Khanam)
UTAS Author:Bezabhe, W (Dr Woldesellassie Bezabhe)
UTAS Author:Stankovich, J (Dr Jim Stankovich)
UTAS Author:Radford, J (Professor Jan Radford)
ID Code:139408
Year Published:2020
Web of Science® Times Cited:10
Deposited By:Medicine
Deposited On:2020-06-15
Last Modified:2021-04-13
Downloads:21 View Download Statistics

Repository Staff Only: item control page